Cartesian Therapeutics, Inc.RNACNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Over Time
Trending higher, above historical average, strong compound growth.
Left:
|
|
|
|

Revenue minus cost of goods sold

Latest
$38.91M
↑ 31% above average
Average (9y)
$29.72M
Historical baseline
Range
High:$108.74M
Low:$207000.00
CAGR
+23.1%
Consistent expansion
PeriodValueChange
2024$38.91M+49.6%
2023$26.00M-76.1%
2022$108.74M+27.8%
2021$85.08M+412.6%
2020$16.60M+148.6%
2019$6.68M+639.4%
2018$903000.00+336.2%
2017$207000.00-97.4%
2016$8.08M+34.5%
2015$6.01M-